REQUEST A DEMO
Total
USD $0.00
Search more companies

Farmacos Darovi S.A. DE C.V. (Mexico)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Farmacos Darovi S.A. DE C.V. Profile Updated: December 13, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Farmacos Darovi is a Mexico-based pharmaceutical company engaged in the development, manufacturing and commercialization of pharmaceutical products. The companys portfolio includes generic and branded medicines oriented to prescription and over-the-counter markets. Its operations cover formulation, production, regulatory compliance and distribution within Mexico. Key assets include pharmaceutical manufacturing facilities and regulatory expertise. Strategically, Farmacos Darovi focuses on product quality, therapeutic effectiveness and access to affordable medicines in the domestic market.

Headquarters
Acalotenco 237 Bodega 107, Col. San Sebastian
Azcapotzalco; Postal Code: 02040

Contact Details: Purchase the Farmacos Darovi S.A. DE C.V. report to view the information.

Website: http://www.farmacosdarovi.com.mx

Basic Information
Total Employees:
Purchase the Farmacos Darovi S.A. DE C.V. report to view the information.
Financial Auditors:
Purchase the Farmacos Darovi S.A. DE C.V. report to view the information.
Incorporation Date:
August 19, 2013
Key Executives
Purchase this report to view the information.
Chief Financial Officer
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Farmacos Darovi S.A. DE C.V. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MXN. Absolute financial data is included in the purchased report.
Net sales revenue
38.04%
Total operating revenue
38.04%
Operating profit (EBIT)
10.9%
Net Profit (Loss) for the Period
24.94%
Total Assets
19.26%
Total Equity
42.09%
Operating Profit Margin (ROS)
-1.68%
Net Profit Margin
-0.58%
Return on Equity (ROE)
-4.07%
Debt/Equity
-48.36%
Quick Ratio
0.17%
Cash Ratio
-0.11%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?